首页> 外文期刊>Infection and immunity >Invariant Vα14 Chain NKT Cells Promote Plasmodium berghei Circumsporozoite Protein-Specific Gamma Interferon- and Tumor Necrosis Factor Alpha-Producing CD8+ T Cells in the Liver after Poxvirus Vaccination of Mice
【24h】

Invariant Vα14 Chain NKT Cells Promote Plasmodium berghei Circumsporozoite Protein-Specific Gamma Interferon- and Tumor Necrosis Factor Alpha-Producing CD8+ T Cells in the Liver after Poxvirus Vaccination of Mice

机译:不变的Vα14链NKT细胞在小鼠痘病毒疫苗接种后在肝脏中促进伯氏疟原虫环子孢子蛋白特异的γ-干扰素和肿瘤坏死因子产生CD8 + T细胞。

获取原文
           

摘要

Understanding the protective mechanism in the liver induced by recombinant vaccines against the pre-erythrocytic stages of malaria is important for vaccine development. Most studies in mice have focused on splenic and peripheral blood T cells and identified gamma interferon (IFN-γ)-producing CD8+ T cells as correlates of protection, which can be induced by prime-boost vaccination with recombinant poxviruses. Invariant natural killer T (Vα14iNKT) cells can also protect against liver stage malaria, when activated, and are abundant in the liver. Since poxviruses have nonspecific immunomodulating effects, which are incompletely understood, we investigated whether recombinant poxviruses affect the protective properties of hepatic Vα14iNKT cells and thus vaccine efficacy. We show that intradermal vaccination with recombinant poxviruses activated Vα14iNKT cells and NK cells in the livers of BALB/c mice while inducing IFN-γ- and tumor necrosis factor alpha (TNF-α)-producing pre-erythrocytic stage antigen-specific CD8+ T cells. Greater numbers of hepatic Vα14iNKT cells secreted interleukin-4 than IFN-γ. Vaccinated Vα14iNKT-cell-deficient mice had lower, but still protective levels of hepatic and splenic IFN-γ+ and TNF-α+ CD8+ T cells and better protection rates later after challenge with Plasmodium berghei sporozoites. Therefore, vaccine-activated hepatic Vα14iNKT cells help in generating specific T cells but are not required for protection induced by recombinant poxviruses. Furthermore, double-positive INF-γ+/TNF-α+ CD8+ T cells were enriched in protected livers, suggesting that cells expressing both of these cytokines may be most relevant for protection.
机译:了解重组疫苗在肝脏中对抗疟疾前红细胞生成阶段的保护机制对于疫苗开发很重要。小鼠中的大多数研究都集中在脾脏和外周血T细胞上,并确定产生γ-干扰素(IFN-γ)的CD8 + T细胞是保护作用的相关因子,可以通过接种初次加强免疫接种来诱导重组痘病毒。不变的自然杀伤T(Vα14 i NKT)细胞在被激活时也可以预防肝阶段疟疾,并且在肝脏中含量丰富。由于痘病毒具有非特异性的免疫调节作用,目前尚未完全了解,因此我们研究了重组痘病毒是否影响肝Vα14 i NKT细胞的保护特性,从而影响疫苗的功效。我们显示重组痘病毒的皮内疫苗接种可激活BALB / c小鼠肝脏中的Vα14 i NKT细胞和NK细胞,同时诱导产生IFN-γ和肿瘤坏死因子α(TNF-α)的前期-红细胞阶段抗原特异性CD8 + T细胞。肝Vα14 i NKT细胞分泌白细胞介素4的数量要多于IFN-γ。接种疫苗的Vα14 i NKT细胞缺陷小鼠的肝脏和脾脏IFN-γ + 和TNF-α + 的保护水平较低,但仍然CD8 + T细胞和伯氏疟原虫子孢子攻击后的保护率更高。因此,疫苗激活的肝Vα14 i NKT细胞有助于产生特异性T细胞,但重组痘病毒诱导的保护不是必需的。此外,双阳性的INF-γ + /TNF-α + CD8 + T细胞在受保护的肝脏中富集,表明这两种细胞均表达这些细胞因子可能与保护最相关。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号